Date
- (-) 2020 (61)
- (-) 1998 (4)
- 2026 (5)
- 2025 (26)
- 2024 (41)
- 2023 (48)
- 2022 (26)
- 2021 (101)
- 2019 (126)
- 2018 (40)
- 2017 (21)
- 2016 (22)
- 2015 (14)
- 2014 (22)
- 2013 (8)
- 2012 (3)
- 2010 (2)
- 2009 (11)
- 2008 (5)
- 2007 (12)
- 2006 (10)
- 2005 (12)
- 2004 (5)
- 2003 (2)
- 2002 (6)
- 2001 (3)
- 2000 (11)
- 1999 (5)
- 1997 (1)
- 1996 (7)
- 1995 (2)
- 1994 (6)
- 1993 (6)
- 1991 (19)
Sponsor content
65 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MenQuadfi meningococcal (Groups A,C,Y,W) polysaccharide tetanus toxoid conjugate vaccine, solution for injection, vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Rifinah 300/150mg.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for APX-CLOPIDOGREL/ASPIRIN 75/100 clopidogrel (as hydrogen sulfate)/aspirin 75 mg/100 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FLUZONE HIGH-DOSE QIV inactivated quadrivalent influenza vaccine (Split Virion) influenza virus haemagglutinin 240 mcg, suspension for injection PFS.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AMDARONE amiodarone hydrochloride 200 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for APX-PARACETAMOL/CODEINE paracetamol 500 mg and codeine phosphate hemihydrate 30 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SARCLISA isatuximab 500 mg/25 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SARCLISA isatuximab 100 mg/5 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ALPROLIX eftrenonacog alfa (rhu) 4000 IU powder for injection vial and diluent pre-filled syringe.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Isatuximab